Affimed (AFMD) Announces Angus Smith as CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Tech stocks bolster Wall Street as Nvidia quells AI growth concerns
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil rises by over $1 as White House says no US-Iran talks happening
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Revolution Medicines prices RASONQUE at $39,800 per month
Affimed Announces Appointment of Angus Smith as Chief Financial Officer
June 11, 2020 6:30 AM EDT
 Mr. Smith brings broad financial management and US capital markets expertise
Heidelberg, Germany, June 11, 2020 Â Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointment of Angus Smith as Chief Financial Officer, completing Affimeds leadership team. Mr. Smith will begin his employment on July 13, 2020 and will be based out of Affimeds New York office.
Mr. Smith has broad biopharmaceutical industry experience including financial strategy, capital markets,... More
